Bcl-xL Cancer Research Results
Bcl-xL, Bcl-xL: Click to Expand ⟱
| Source: |
| Type: pro-survival proteins |
The proteins of BCL-2 family are classified into three subgroups, i.e., the anti-apoptotic/pro-survival proteins represented by BCL-2 and BCL-XL.
BCL-XL overexpressing cells exhibited higher tumors sphere formation capacity and expressed higher levels of some stem cell markers, supporting the concept that BCL-XL plays essential roles in the maintenance of cancer stem cell phenotype.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
HDAC↓, AntiTum↑, TumCMig↓, AMPK↑, mTOR↑, TumAuto↑, ROS↑, miR-139-5p↑, BMI1↓, TumCI?, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, Bcl-xL↓, MMP↓, PINK1↑, PARK2↑, TumMeta↓, TumCG↓, LC3II↑, p62↓, eff↓,
| - |
in-vitro, |
CLL, |
KBM-5 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
Apoptosis↑, ChemoSen↑, IAP1↓, IAP2↓, Bcl-2↓, Bcl-xL↓, TRAF1↓, cycD1/CCND1↓, cMyc↓, COX2↓, MMP9↓, angioG↓, VEGF↓, NF-kB↓, eff↓,
| - |
in-vitro, |
GC, |
SNU16 |
|
|
|
- |
in-vitro, |
Nor, |
GES-1 |
|
|
|
TumCP↓, Apoptosis↑, BAX↑, BAD↑, Cyt‑c↑, cl‑PARP↑, cl‑Casp3↑, Bcl-2↓, Bcl-xL↓, p‑PI3K↓, p‑Akt↓, Ki-67↓, toxicity↓, RadioS↑,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
PARK2↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1, PINK1↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, cMyc↓, 1,
Cell Death ⓘ
p‑Akt↓, 1, Apoptosis↑, 2, BAD↑, 1, BAX↑, 2, Bcl-2↓, 3, Bcl-xL↓, 3, cl‑Casp3↑, 2, Cyt‑c↑, 1, IAP1↓, 1, IAP2↓, 1,
Autophagy & Lysosomes ⓘ
LC3II↑, 1, p62↓, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
cl‑PARP↑, 2,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
BMI1↓, 1, HDAC↓, 1, mTOR↑, 1, p‑PI3K↓, 1, TumCG↓, 1,
Migration ⓘ
E-cadherin↑, 1, Ki-67↓, 1, miR-139-5p↑, 1, MMP9↓, 1, N-cadherin↓, 1, Snail↓, 1, TumCI?, 1, TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 1, Vim↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, NF-kB↓, 1, TRAF1↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, eff↓, 2, RadioS↑, 1,
Clinical Biomarkers ⓘ
Ki-67↓, 1,
Functional Outcomes ⓘ
AntiTum↑, 1, toxicity↓, 1,
Total Targets: 48
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Bcl-xL, Bcl-xL
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:28 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page